February 10, 2009 – Personalized medicine will be the main topic for healthcare executives, radiologists, pathologists and information technology (IT) professionals at the second annual Molecular Summit in Philadelphia on Feb. 10-11.
Siemens Healthcare and The Dark Report bring together industry experts in molecular imaging, molecular diagnostics and IT, to discuss rapidly advancing trends in the integration of imaging and clinical laboratory diagnostics as a means to enhance predictive diagnosis and tailor effective treatment to the individual.
The Molecular Summit hopes to build on the success of last year’s program.
Conference attendees may choose from a selection of 26 educational sessions that describe how innovators are advancing clinical care and enhancing their financial strength by incorporating the latest molecular imaging techniques in tandem with emerging molecular diagnostics. Industry pioneers will speak about evolving changes in R&D, the discovery of new medicines, effective policies to translate these discoveries into better outcomes for patients, resulting treatments that improve healthcare, and new business strategies to advance the field of personalized medicine. Continuing Education Units (CEUs) are provided by the American Association of Clinical Chemistry (AACC).
More information: www.molecular-summit.com, www.usa.siemens.com/healthcare
April 10, 2024 
![(A) PET images of [68Ga]Ga-DOTA-ZCAM241 uptake at baseline and 3, 7, and 12 days after injection as inflammatory arthritis developed in single representative individual mouse. Images are normalized to SUV of 0.5 for direct comparison between time points. (B) CD69 immunofluorescence Sytox (Thermo Fisher Scientific) staining of joints of representative animals during matching time points.](/sites/default/files/styles/feed_medium/public/PET%20Tracers.jpeg?itok=P5Di6MIe)
